Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Gross Margin (2024 - 2025)

Historic Gross Margin for X4 Pharmaceuticals (XFOR) over the last 2 years, with Q3 2025 value amounting to 80.11%.

  • X4 Pharmaceuticals' Gross Margin rose 206500.0% to 80.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 83.26%, marking a year-over-year increase of 273400.0%. This contributed to the annual value of 69.35% for FY2024, which is N/A changed from last year.
  • As of Q3 2025, X4 Pharmaceuticals' Gross Margin stood at 80.11%, which was up 206500.0% from 83.48% recorded in Q2 2025.
  • In the past 5 years, X4 Pharmaceuticals' Gross Margin ranged from a high of 83.63% in Q1 2025 and a low of 52.4% during Q2 2024